Literature DB >> 10788427

Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases.

C Busch1, F Hofmann, R Gerhard, K Aktories.   

Abstract

Large clostridial cytotoxins catalyze the glucosylation of Rho/Ras GTPases using UDP-glucose as a cosubstrate. By site-directed mutagenesis of Clostridium sordellii lethal toxin and Clostridium difficile toxin B fragments, we identified tryptophan 102, which is located in a conserved region within the catalytic domain of all clostridial cytotoxins, to be crucial for UDP-glucose binding. Exchange of Trp-102 with alanine decreased the glucosyltransferase activity by about 1,000-fold and blocked cytotoxic activity after microinjection. Replacement of Trp-102 by tyrosine caused a 100-fold reduction in enzyme activity, indicating a partial compensation of the tryptophan function by tyrosine. Decrease in glucosyltransferase and glycohydrolase activity was caused predominantly by an increase in the K(m) for UDP-glucose of these mutants. The data indicate that the conserved tryptophan residue is implicated in the binding of the cosubstrate UDP-glucose by large clostridial cytotoxins. Data bank searches revealed different groups of proteins sharing the recently identified DXD motif (Busch, C., Hofmann, F., Selzer, J., Munro, J., Jeckel, D., and Aktories, K. (1998) J. Biol. Chem. 273, 19566-19572) and a conserved region defined by a tryptophan residue equivalent to Trp-102 of C. sordellii lethal toxin. From our findings, we propose a novel family of glycosyltransferases which includes both prokaryotic and eukaryotic proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788427     DOI: 10.1074/jbc.275.18.13228

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effects.

Authors:  Matthias Teichert; Helma Tatge; Janett Schoentaube; Ingo Just; Ralf Gerhard
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

5.  Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi.

Authors:  Rodrigo Fernandez-Valdivia; Hideyuki Takeuchi; Amin Samarghandi; Mario Lopez; Jessica Leonardi; Robert S Haltiwanger; Hamed Jafar-Nejad
Journal:  Development       Date:  2011-04-13       Impact factor: 6.868

6.  Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.

Authors:  Joseph W Alvin; D Borden Lacy
Journal:  J Struct Biol       Date:  2017-04-19       Impact factor: 2.867

7.  Rac GTPase plays an essential role in exocytosis by controlling the fusion competence of release sites.

Authors:  Yann Humeau; Michel R Popoff; Hiroshi Kojima; Frédéric Doussau; Bernard Poulain
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Actin re-organization induced by Chlamydia trachomatis serovar D--evidence for a critical role of the effector protein CT166 targeting Rac.

Authors:  Jessica Thalmann; Katrin Janik; Martin May; Kirsten Sommer; Jenny Ebeling; Fred Hofmann; Harald Genth; Andreas Klos
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

9.  Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.

Authors:  Jordi M Lanis; Soumitra Barua; Jimmy D Ballard
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 10.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.